{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:24:23Z","timestamp":1781774663171,"version":"3.54.5"},"reference-count":105,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3987,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1111\/j.1396-0296.2004.04044.x","type":"journal-article","created":{"date-parts":[[2004,9,20]],"date-time":"2004-09-20T12:54:34Z","timestamp":1095684874000},"page":"409-426","source":"Crossref","is-referenced-by-count":34,"title":["Infliximab"],"prefix":"10.1155","volume":"17","author":[{"given":"Laura S.","family":"Winterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Menter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"key":"b1_418","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371679"},{"issue":"7","key":"b2_419","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","volume":"124","author":"Van Den Brande JM","year":"2003","journal-title":"Gastroenterology"},{"key":"b3_420","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12335758"},{"key":"b4_421","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu354xx"},{"key":"b5_422","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00622.x"},{"key":"b6_423","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120568"},{"key":"b7_424","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.37.26287"},{"key":"b8_425","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","volume":"96","author":"Ettehadi P","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"b9_426","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1993.tb03457.x","volume":"94","author":"Kristensen M","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"b10_427","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00749.x"},{"key":"b11_428","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(96)00562-2"},{"key":"b12_429","first-page":"1544","volume":"25","author":"Ritchlin C","year":"1998","journal-title":"J Rheumatol"},{"key":"b13_430","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/art.1780360705","volume":"36","author":"Veale D","year":"1993","journal-title":"Arthritis Rheum"},{"key":"b14_431","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03349.x"},{"key":"b15_432","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/BF00402220","volume":"286","author":"De Boer O","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"b16_433","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01306.x"},{"key":"b17_434","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-0436.1998.6320093.x"},{"key":"b18_435","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12874977"},{"key":"b19_436","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2000.00001.x"},{"issue":"1","key":"b20_437","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","volume":"102","author":"Xia AY","year":"2003","journal-title":"Blood"},{"key":"b21_438","first-page":"1117","volume":"26","author":"Costello PJ","year":"1999","journal-title":"J Rheumatol"},{"key":"b22_439","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01143-5"},{"key":"b23_440","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(93)90106-L"},{"key":"b24_441","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.301.2.418"},{"key":"b25_442","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1995.0029"},{"key":"b26_443","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.2.206"},{"key":"b27_444","doi-asserted-by":"publisher","DOI":"10.1186\/ar549"},{"key":"b28_445","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.10"},{"key":"b29_446","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.105948"},{"key":"b30_447","doi-asserted-by":"crossref","unstructured":"30. TH Andersen, and NJ Moerk . Infliximab therapy in patients with severe active refractory pyoderma gangrenosum . Presented at: The American Academy of Dermatology 62nd Annual Meeting. Washington, DC: 2004, Abstract P39.","DOI":"10.1016\/j.jaad.2003.10.045"},{"key":"b31_448","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012664"},{"key":"b32_449","doi-asserted-by":"crossref","unstructured":"32. A Jacobi, G Schuler, and M Hertl . Long-term efficacy and safety of TNF-alpha-inhibitor infliximab in severe atopic dermatitis . Presented at: The American Academy of Dermatology 62nd Annual Meeting.Washington, DC: 2004, Abstract P10.","DOI":"10.1016\/j.jaad.2003.10.016"},{"key":"b33_450","doi-asserted-by":"crossref","unstructured":"33. SL Jensen, and C Leonardi . Novel uses of infliximab in dermatology . Presented at: The American Academy of Dermatology 62nd Annual Meeting.Washington, DC: 2004, Abstract P139.","DOI":"10.1016\/j.jaad.2003.10.144"},{"key":"b34_451","unstructured":"34. CT Lee, J Dempsey, J Miller, and L King . Hidradenitis suppurative: response to treatment with infliximab . Presented at: The American Academy of Dermatology 62nd Annual Meeting. Washington, DC: 2004, Abstract P171."},{"key":"b35_452","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200111000-00008"},{"key":"b36_453","doi-asserted-by":"crossref","unstructured":"36. J Pardo, P Mercader, J Sanchez-Carazo, and V Oliver . Infliximab in the management of severe pemphigus vulgaris . Presented at: The American Academy of Dermatology 62nd Annual Meeting. Washington, DC: 2004, Abstract P361.","DOI":"10.1016\/j.jaad.2003.10.303"},{"key":"b37_454","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W"},{"key":"b38_455","first-page":"S94","volume":"44","author":"Brockbank JE","year":"2001","journal-title":"Arthritis Rheum"},{"key":"b39_456","first-page":"1071","volume-title":"Kelley's Textbook of Rheumatology.","author":"Gladman DD","year":"2001"},{"key":"b40_457","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04089.x"},{"key":"b41_458","doi-asserted-by":"publisher","DOI":"10.1002\/art.10671"},{"key":"b42_459","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"Frederiksson T","year":"1978","journal-title":"Dermatologica"},{"key":"b43_460","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-002-0246-3"},{"key":"b44_461","unstructured":"44. C Antoni, S Smolen, and IMPACT Study Group. , The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) . Presented at: The 61st Annual Meeting of the American Academy of Dermatology. San Francisco, CA: 2003 ."},{"key":"b45_462","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04954-0"},{"key":"b46_463","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.307"},{"key":"b47_464","unstructured":"47. AB Gottlieb, R Evans, and A Menter . The efficacy and safety of infliximab induction therapy in subjects with severe plaque-type psoriasis . Presented at: The 61st Annual Meeting of the American Academy of Dermatology. San Francisco, CA: 2003 ."},{"key":"b48_465","unstructured":"48. AB Gottlieb, S Li, R Evans, and A Menter . Infliximab in the treatment of psoriasis: results from the first 10 weeks of the phase II trial . Presented at: The 61st Annual Meeting of the American Academy of Dermatology. San Francisco, CA: 2003 ."},{"key":"b49_466","doi-asserted-by":"crossref","unstructured":"49. AB Gottlieb, R Evans, M Matheson, and B Miller . The efficacy of infliximab in specific areas of the body . Presented at: The American Academy of Dermatology 62nd Annual Meeting.Washington, DC: 2004, Abstract P614.","DOI":"10.1016\/j.jaad.2003.10.555"},{"key":"b50_467","doi-asserted-by":"crossref","unstructured":"50. AB Gottlieb, R Evans, K Patel, and M Mattheson . Infliximab improves signs of plaque psoriasis in patients with psoriatic arthritis . Presented at: The American Academy of Dermatology 62nd Annual Meeting. Washington, DC: 2004, Abstract P612.","DOI":"10.1016\/j.jaad.2003.10.553"},{"key":"b51_468","doi-asserted-by":"crossref","unstructured":"51. AB Gottlieb, R Evans, S Li, and C Leonardi . The efficacy of infliximab across a variety of subgroups with plaque psoriasis . Presented at: The American Academy of Dermatology 62nd Annual Meeting:Washington, DC: 2004, Abstract P615.","DOI":"10.1016\/j.jaad.2003.10.556"},{"key":"b52_469","doi-asserted-by":"crossref","unstructured":"52. SR Feldman, M Bala, A Menter, and KB Gordon . The quality of life of patients with severe psoriasis treated with infliximab . Presented at: The American Academy of Dermatology 62nd Annual Meeting. Washington, DC: 2004, Abstract P7.","DOI":"10.1016\/j.jaad.2003.10.013"},{"key":"b53_470","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00027.x"},{"key":"b54_471","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905063401804"},{"key":"b55_472","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","volume":"98","author":"Cheiftez A","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"b56_473","unstructured":"56. GW Cannon, V Strand, L Scarazzini, and WL Holden . Comparison of adverse event reporting rates for etanercept, infliximab, leflunamide, and methotrexate . Presented at: 2003 American College of Rheumatology Annual Scientific Meeting.Orlando, Florida."},{"key":"b57_474","unstructured":"57. EM Ruderman, and JA Markenson . Granulomatous infections and tumor necrosis factor antagonist therapies: update through June 2002 . Presented at: 2003 American College of Rheumatology Annual Scientific Meeting.Orlando, Florida."},{"key":"b58_475","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"b59_476","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"b60_477","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00448-1"},{"issue":"1","key":"b61_478","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0016-5085(03)00701-7","volume":"125","author":"Vermeire S","year":"2003","journal-title":"Gastroenterology"},{"key":"b62_479","doi-asserted-by":"publisher","DOI":"10.1002\/art.10679"},{"key":"b63_480","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0016-5085(99)70294-5","volume":"117","author":"Bickston SJ","year":"1999","journal-title":"Gastroenterology"},{"key":"b64_481","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01023.x"},{"issue":"1","key":"b65_482","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2133.2003.05384.x","volume":"149","author":"Mahe E","year":"2003","journal-title":"Br J Dermatol"},{"key":"b66_483","doi-asserted-by":"publisher","DOI":"10.1038\/10552"},{"key":"b67_484","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03539.x"},{"key":"b68_485","doi-asserted-by":"crossref","unstructured":"68. AC Esser, A Abril, S Fayn, and J Doyl . Development of multiple nonmelanoma skin cancers after treatment with infliximab . Presented at: The American Academy of Dermatology 62nd Annual Meeting.Washington, DC: 2004, Abstract P152.","DOI":"10.1016\/j.jaad.2003.10.156"},{"key":"b69_486","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)00811-9"},{"key":"b70_487","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1172\/JCI116834","volume":"92","author":"Yokoyama T","year":"1993","journal-title":"J Clin Invest"},{"key":"b71_488","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00470-9"},{"key":"b72_489","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"b73_490","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-138-10-200305200-00008","volume":"138","author":"Kwon HJ","year":"2003","journal-title":"Ann Intern Med"},{"key":"b74_491","unstructured":"74. F Wolfe, and K Michaud . Congestive heart failure in rheumatoid arthritis: rates, predictors and the effect of anti-TNF therapy . Presented at: American College of Rheumatology Annual Scientific Meeting. Orlando, Florida: 2003 ."},{"key":"b75_492","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80075-3"},{"key":"b76_493","first-page":"37","volume":"112","author":"Wagner CL","year":"2003","journal-title":"Dev Biol"},{"issue":"7","key":"b77_494","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","volume":"348","author":"Baert F","year":"2003","journal-title":"N Engl J Med"},{"key":"b78_495","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"b79_496","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432202"},{"key":"b80_497","unstructured":"80. R Maini, F Breedveld, and J Kalden , et al.Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial: Results at 102 weeks . ATTRACT Study Group. Arthritis Rheum2004 (in press)."},{"key":"b81_498","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"b82_499","unstructured":"82. CW Marano, R Evans, C Guzzo, A Menter, S Li, and C Wagner . Immunogenicity of infliximab (REMICADE) and its effect on safety in patients with severe plaque-type psoriasis . Presented at: The 61st Annual Meeting of the American Academy of Dermatology:San Francisco, CA: 2003 ."},{"key":"b83_500","first-page":"1181","volume-title":"Physicians' Desk Reference.","year":"2002"},{"key":"b84_501","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6"},{"key":"b85_502","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200102000-00016"},{"issue":"1","key":"b86_503","first-page":"107","volume":"31","author":"Oniankitan O","year":"2004","journal-title":"J Rheumatol"},{"key":"b87_504","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.11.1078"},{"key":"b88_505","first-page":"S152","volume":"44","author":"Antoni CE","year":"2001","journal-title":"Arthritis Rheum"},{"key":"b89_506","doi-asserted-by":"publisher","DOI":"10.1016\/mjd.2003.558"},{"issue":"3","key":"b90_507","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(99)70363-4","volume":"41","author":"Koo J","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"b91_508","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)00803-X"},{"key":"b92_509","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117725"},{"key":"b93_510","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103223441207"},{"key":"b94_511","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(00)00167-5"},{"key":"b95_512","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001253200"},{"key":"b96_513","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0733-8635(05)70306-5","volume":"19","author":"Gottlieb AB","year":"2001","journal-title":"Dermatol Clin"},{"key":"b97_514","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00769991","volume":"11","author":"Wilmer JL","year":"1995","journal-title":"Cell Biol Toxicol"},{"key":"b98_515","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01306.x"},{"key":"b99_516","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-0436.1998.6320093.x"},{"key":"b100_517","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050317"},{"key":"b101_518","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050299"},{"key":"b102_519","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1096\/fasebj.13.14.2002","volume":"13","author":"Frank S","year":"1999","journal-title":"Faseb J"},{"key":"b103_520","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(99)00062-6"},{"key":"b104_521","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12344019"},{"key":"b105_522","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12313437"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1396-0296.2004.04044.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1396-0296.2004.04044.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T11:16:50Z","timestamp":1705231010000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1396-0296.2004.04044.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1396-0296.2004.04044.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1396-0296.2004.04044.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}